Abstract
A microbiological analysis of 102 patients suffering from cystic fibrosis was conducted over a 22 month period. 20 microbial species with the following incidence were identified: Pseudomonas aeruginosa: 83.4%; Candida albicans: 29.4%; Staphylococcus aureus: 24.5%; Staphylococcus epidermidis: 11.8%; Haemophilus influenzae: 11.8%; Streptococcus pneumoniae; 6.9%; Pseudomonas maltophilia: 6.8%; Aspergillus fumigatus: 5.9%. Other species were present in less than 5% of the patients. In the majority of specimens with P. aeruginosa, more than one type (up to six) was detectable. These strains were identical in colony appearance, O-serotype and pyocin-type. Quantitative analysis revealed concentrations of colony-forming units of 10(7) to 10(9) for P. aeruginosa, 10(6) to 10(8) for P. maltophilia, 10(4) to 10(7) for S. aureus, 10(4) to 10(6) for S. epidermidis and 10(4) to 10(7) for C. albicans in the majority of specimens. Significant differences were observed in the time periods during which the pathogens persisted in the patients. Maximum persistence was observed for P. aeruginosa. P. maltophilia and A. fumigatus had about similar persistence rates, which were lower than those for P. aeruginosa but above those for S. aureus and H. influenzae. S. epidermidis was eliminated within shorter periods than S. aureus. C. albicans, although the second most frequent microorganism identified, showed a very low persistence rate. The microbiological analysis confirms results from other research centers (high incidence of P. aeruginosa), but reveals significant regional differences as well (Pseudomonas cepacia not detectable, higher incidence of P. maltophilia and C. albicans). This underlines the necessity for detailed qualitative and quantitative microbiological analysis of sputa from cystic fibrosis patients as a prerequisite for rational analysis of etiological, epidemiological and therapeutical aspects of cystic fibrosis.
MeSH Terms
Adolescent
Adult
Bacteria/growth & development,isolation & purification
Child
Child, Preschool
Cystic Fibrosis/microbiology
Female
Haemophilus influenzae/growth & development,isolation & purification
Humans
Male
Mitosporic Fungi/growth & development,isolation & purification
Pseudomonas/growth & development,isolation & purification
Pseudomonas aeruginosa/growth & development,isolation & purification
Sputum/microbiology
Staphylococcus/growth & development,isolation & purification
Streptococcus pneumoniae/growth & development,isolation & purification
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Bauernfeind A
Max-von-Pettenkofer-Institut, Munich.
Bertele R M
Harms K
Hörl G
Jungwirth R
Petermüller C
Przyklenk B
Weisslein-Pfister C
References (20)
20 references, click to expand
-
Why is Pseudomonas the colonizer and why does it persist?
Infection. 1987 Jul-Aug;15(4):281-7
PMID: 3117702
-
Selective media for the quantitation of bacteria in cystic fibrosis sputum.
J Med Microbiol. 1984 Apr;17(2):113-9
PMID: 6423825
-
Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa.
Infection. 1987 Jul-Aug;15(4):278-80
PMID: 3117701
-
Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.
J Clin Microbiol. 1980 Jun;11(6):552-7
PMID: 6776135
-
Rational parameters for antibiotic therapy in patients with cystic fibrosis.
Infection. 1987 Jul-Aug;15(4):300-7
PMID: 3117704
-
A simple test system for the separation of staphylococci from micrococci.
J Clin Microbiol. 1975 Mar;1(3):337-8
PMID: 1100662
-
Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood.
Arch Dis Child. 1980 May;55(5):348-53
PMID: 7002053
-
Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis.
J Pediatr. 1984 Mar;104(3):352-6
PMID: 6423790
-
Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981.
J Infect Dis. 1984 Feb;149(2):283
PMID: 6421945
-
Frequency of Aspergillus fumigatus isolates and antibodies to aspergillus antigens in cystic fibrosis.
Acta Pathol Microbiol Immunol Scand B. 1985 Apr;93(2):105-12
PMID: 3893030
-
RESPIRATORY TRACT BACTERIOLOGY IN CYSTIC FIBROSIS.
Am J Dis Child. 1963 Sep;106:315-24
PMID: 14057614
-
Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis.
Helv Paediatr Acta. 1982;37(6):547-54
PMID: 6820015
-
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.
J Pediatr. 1984 Feb;104(2):206-10
PMID: 6420530
-
Celiac syndrome; chemotherapy in infections of the respiratory tract associated with cystic fibrosis of the pancreas; observations with penicillin and drugs of the sulfonamide group, with special reference to penicillin aerosol.
Am J Dis Child. 1946 Jul;72:17-61
PMID: 20994054
-
Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.
J Infect Dis. 1979 Dec;140(6):873-80
PMID: 120383
-
[Aspergillus fumigatus infection of the lung in cystic fibrosis (author's transl)].
Dtsch Med Wochenschr. 1980 Mar 28;105(13):442-5
PMID: 6988190
-
Allergic bronchopulmonary aspergillosis in cystic fibrosis.
J Allergy Clin Immunol. 1984 Jan;73(1 Pt 1):44-8
PMID: 6693666
-
Aspergillosis and atopy in cystic fibrosis.
Am Rev Respir Dis. 1979 Oct;120(4):863-73
PMID: 507513
-
Aspergillus antibody in patients with cystic fibrosis.
Am J Dis Child. 1975 Oct;129(10):1164-7
PMID: 1103615
-
Revised pyocin typing method for Pseudomonas aeruginosa.
J Clin Microbiol. 1984 Jul;20(1):47-50
PMID: 6430955